Atlas Trials

Placebo-controlled Trial of 5-hydroxytryptophan and Creatine for SSRI or SNRI Augmentation in Treatment Resistant Depression in Females

Clinical trial NCT02922725 · TERMINATED

Trial details

NCT number
NCT02922725
Sponsor
Brent Michael Kious, MD, PhD
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2016-11-01
Primary completion
2020-05-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.